Skip to main content
. 2013 Jun;23(6):758–765. doi: 10.1089/thy.2012.0488

Table 2.

Number (Percent) of Women on Antithyroid Therapy by Thyrotoxicosis Category

 
Thyrotoxicosis category
 
 
 
TTX-1a(N=3304)
TTX-2 (but not TTX-1)b(N=4746)
No TTX (N=801,551)
Total (N=809,601)
Therapy used by women at any time during the study period n (%) n (%) n (%) n (%)
MMI 1021 (30.9) 683 (14.4) 87 (0.01) 1791 (0.22)
PTU 1166 (35.3) 854 (18.0) 103 (0.01) 2123 (0.26)
MMI or PTU 1758 (53.2) 1390 (29.3) 176 (0.02) 3324 (0.41)
MMI and PTU 429 (13.0) 147 (3.1) 14 (<0.01) 590 (0.07)
MMI only (no PTU) 592 (17.9) 536 (11.3) 73 (0.01) 1201 (0.15)
PTU only (no MMI) 737 (22.3) 707 (14.9) 89 (0.01) 1533 (0.19)
Neither MMI nor PTU 1546 (46.8) 3356 (70.7) 801,375 (>99.9) 806,277 (99.6)
THRT 1433 (43.4) 1491 (31.4) 45,900 (5.73) 48,824 (6.03)
RAI 5 (0.15) 8 (0.17) 87 (0.01) 100 (0.01)
Thyroidectomy 103 (3.12) 94 (1.98) 1011 (0.13) 1208 (0.15)
a

TTX-1 applies to women with an ICD-9-CM diagnosis code of 242.0x at any time during study period.

b

TTX-2 (but not TTX-1) applies to women who do not have an ICD-9-CM diagnosis code of 242.0x, but do have a code of 242.9 at any time during study period.

THRT, thyroid hormone replacement therapy; RAI, radioactive iodine.